BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23846779)

  • 1. Novel factors to improve prediction of nodal positivity in patients with clinical T1/T2 breast cancers.
    Torstenson T; Shah-Khan MG; Hoskin TL; Morton MJ; Adamczyk DL; Jones KN; Case J; Chartier S; Boughey JC
    Ann Surg Oncol; 2013 Oct; 20(10):3286-93. PubMed ID: 23846779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases.
    Ansari B; Morton MJ; Adamczyk DL; Jones KN; Brodt JK; Degnim AC; Jakub JW; Lohse CM; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3174-80. PubMed ID: 21861233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the sentinel node frozen section result on the probability of additional nodal metastases as predicted by the MSKCC nomogram in breast cancer.
    Jamal MH; Rayment JH; Meguerditchian A; Doi SA; Meterissian S
    Jpn J Clin Oncol; 2011 Mar; 41(3):314-9. PubMed ID: 21149238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
    Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement.
    Meretoja TJ; Strien L; Heikkilä PS; Leidenius MH
    Ann Surg Oncol; 2012 Feb; 19(2):567-76. PubMed ID: 21792511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
    Houpu Y; Fei X; Yang Y; Fuzhong T; Peng L; Bo Z; Lin C; Yingming C; Miao L; Hongjun L; Siyuan W; Yuan P; Danhua S; Shu W
    J Surg Oncol; 2019 Sep; 120(4):587-592. PubMed ID: 31309573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
    Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
    Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.
    Tanaka S; Sato N; Fujioka H; Takahashi Y; Kimura K; Iwamoto M
    Surg Today; 2013 Feb; 43(2):163-70. PubMed ID: 22722328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
    Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.